SCHEMBL8925928

SCHEMBL8925928

N[C@@H]1CCN(Cc2ccccc2)[C@@H](Cc2ccccc2)C1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.50
CCR3 P51677 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA4 P22748 2/20 0.44
CA9 Q16790 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3652328 1.00 TACR1 (0.50) TACR1CCR3CA1CA2CA4
SCHEMBL8925926 1.00 TACR1 (0.50) TACR1CCR3CA1CA2CA4
SCHEMBL18640258 0.92 TACR1 (0.47) TACR1
SCHEMBL18640306 0.87 CHRNA7 (0.50) TACR1
SCHEMBL14155625 0.86 SIGMAR1 (0.45)
SCHEMBL18640230 0.85 TACR1 (0.48) TACR1CCR3
SCHEMBL6994439 0.84 SIGMAR1 (0.53) CA1CA2CA4CA9
SCHEMBL18640284 0.84 TACR1 (0.47) TACR1
SCHEMBL6853109 0.83 CCR3 (0.53) CCR3
SCHEMBL18640277 0.83 CYP2D6 (0.53) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646144-A FOR TREATING DISORDERS IN WHICH SUBSTANCE P PLAYS A PART IN DEVELOPMENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
US-5541195-A SUBSTANCE P ANTAGONISTS CIBA-GEIGY CORPORATION (US) 1996-07-30 US disclosed
EP-0532456-B1 1-Acylpiperidine derivatives and their use as substance P antagonists CIBA GEIGY AG (CH) 1995-03-29 EP disclosed
US-5310743-A Substance P antagonist CIBA-GEIGY CORP. (US) 1994-05-10 US disclosed
EP-0532456-A1 1-Acylpiperidine derivatives and their use as substance P antagonists CIBA-GEIGY AG (CH) 1993-03-17 EP disclosed